Downs Christopher 4
4 · CNS Pharmaceuticals, Inc. · Filed Aug 25, 2020
Insider Transaction Report
Form 4
Downs Christopher
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-08-24$2.04/sh+142,000$289,680→ 142,000 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.84 to $2.30. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.